Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Xeris Biopharma Holdings Stock News

XERSNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$5.81

0.387.00%

At close: -

$5.84

0.030.52%

After Hours: Mar 21, 7:58 PM EDT

Xeris Biopharma Holdings (XERS) Forecast

News

Earnings Xeris Biopharma Holdings (XERS) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Xeris Biopharma Holdings Stock News | NASDAQ:XERS | Benzinga

Get the latest news on Xeris Biopharma Holdings stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Xeris Biopharma Holdings performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, March 17, 2025

Xeris Announces FDA Approval Of Supplemental ...
Benzinga Newsdesk

Friday, March 07, 2025

Piper Sandler Reiterates Neutral on Xeris Bio...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Xeris B...
Benzinga Newsdesk

Thursday, March 06, 2025

Xeris Biopharma shares are trading higher aft...
Benzinga Newsdesk
Xeris Biopharma Expects 2025 Revenue Of $255M...
Benzinga Newsdesk
Xeris Biopharma Holdings Q4 2024 GAAP EPS $(0...
Benzinga Newsdesk
Earnings Scheduled For March 6, 2025
Benzinga Insights

Monday, February 03, 2025

Jefferies Reiterates Buy on Xeris Biopharma H...
Benzinga Newsdesk

Tuesday, January 21, 2025

American Diabetes Association And Xeris BioPh...
Benzinga Newsdesk

Friday, January 10, 2025

Xeris Biopharma Expects To Generate 2024 Reve...
Benzinga Newsdesk

Monday, November 11, 2024

HC Wainwright & Co. Maintains Buy on Xeris Bi...
Benzinga Newsdesk
Sapiens International Posts Downbeat Results, Joins Sky Harbour And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Avi Kapoor
Piper Sandler Downgrades Xeris Biopharma Hold...
Benzinga Newsdesk

Friday, November 08, 2024

Xeris Biopharma Raises Its 2024 Revenue Guida...
Benzinga Newsdesk
Xeris Biopharma Holdings Q3 2024 Adj EPS $(0....
Benzinga Newsdesk

Thursday, November 07, 2024

Earnings Outlook For Xeris Biopharma Holdings
Benzinga Insights

Thursday, August 15, 2024

HC Wainwright & Co. Reiterates Buy on Xeris B...
Benzinga Newsdesk

Wednesday, August 14, 2024

More Than $20M Bet On Precigen? Check Out These 3 Stocks Under $5 Insiders Are Aggressively Buying
Avi Kapoor

Tuesday, August 13, 2024

Xeris Biopharma And 2 Other Penny Stocks Insiders Are Buying
Avi Kapoor

Thursday, August 08, 2024

Xeris Biopharma shares are trading higher aft...
Benzinga Newsdesk
Xeris Biopharma Revised FY24 Total Revenue Ou...
Benzinga Newsdesk
Xeris Biopharma Holdings Q2 2024 GAAP EPS $(0...
Benzinga Newsdesk

Monday, July 08, 2024

Xeris Biopharma Reports Preliminary Q2 Total ...
Benzinga Newsdesk
Xeris Biopharma Names John Shannon To Succeed...
Benzinga Newsdesk

Friday, May 31, 2024

HC Wainwright & Co. Reiterates Buy on Xeris B...
Benzinga Newsdesk

Thursday, May 30, 2024

12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Xeris Reports Topline Results From Its Recent...
Benzinga Newsdesk

Monday, May 13, 2024

Socket Mobile And 3 Other Stocks Under $3 Insiders Are Buying
Avi Kapoor

Friday, May 10, 2024

Piper Sandler Reiterates Overweight on Xeris ...
Benzinga Newsdesk

Thursday, May 09, 2024

Xeris Biopharma Raises FY24 Total Revenue Out...
Benzinga Newsdesk
Xeris Biopharma Holdings Q1 EPS $(0.14) Misse...
Benzinga Newsdesk

Monday, May 06, 2024

Why Are Xeris Biopharma Shares Moving Monday?
Dylan Berman
Xeris shares are trading higher after the com...
Benzinga Newsdesk
Xeris Biopharma Enters Into an Exclusive Worl...
Benzinga Newsdesk

Thursday, March 28, 2024

Xeris Biopharma Holdings shares are trading h...
Benzinga Newsdesk
Oppenheimer Initiates Coverage On Xeris Bioph...
Benzinga Newsdesk

Thursday, March 07, 2024

HC Wainwright & Co. Maintains Buy on Xeris Bi...
Benzinga Newsdesk

Wednesday, March 06, 2024

Xeris Biopharma Holdings shares are trading l...
Benzinga Newsdesk
Xeris Biopharma Expects 2024 Revenue Of $170M...
Benzinga Newsdesk
Xeris Biopharma Holdings Q4 GAAP EPS $(0.10),...
Benzinga Newsdesk
Xeris Refinances Its $150M Senior Secured Ter...
Benzinga Newsdesk
Earnings Scheduled For March 6, 2024
Benzinga Insights

Tuesday, March 05, 2024

Earnings Outlook For Xeris Biopharma Holdings
Benzinga Insights

Wednesday, January 10, 2024

Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Xeris Biopharma Enters Into An Exclusive Worl...
Benzinga Newsdesk

Thursday, January 04, 2024

Xeris Biopharma shares are trading higher aft...
Benzinga Newsdesk
Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
Xeris Biopharma Sees FY23 Revenue At High End...
Benzinga Newsdesk

Monday, November 13, 2023

HC Wainwright & Co. Maintains Buy on Xeris Bi...
Benzinga Newsdesk

Friday, November 10, 2023

Piper Sandler Maintains Overweight on Xeris B...
Benzinga Newsdesk

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved